Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

We'd appreciate your feedback.Tell us what you think! opens in new tab/window

Elsevier
Publish with us
AI-Generated response:

Is there a loading dose for zosyn?

Answer generated on June 4, 2024

The AI-generated responses are for illustration purposes only and should not be used for medical purposes.

No, there is no loading dose specified for Zosyn (piperacillin/tazobactam) in the provided sources.

  • The typical dosing regimen for Zosyn involves administering specific amounts at regular intervals depending on the infection being treated, but none of the sources mention a higher initial "loading" dose.[1-3]

  • For adults with various infections, the usual dosages range from 3.375 g to 4.5 g of Zosyn administered intravenously every 6 to 8 hours.[1-3]

  • In pediatric patients, the dosage is often calculated based on body weight, with maximum dose limits specified.[1-3]

  • For patients with renal impairment, dosages need to be adjusted according to the degree of renal function.[2]

  • Administration instructions emphasize infusing Zosyn over 30 minutes, which is standard across various indications and patient groups.[2-3]

Additional info

It's important to note that while Zosyn does not require a loading dose, the initiation of therapy should be timely, especially in critical conditions such as septic shock or nosocomial pneumonia, where therapy should start within specific time frames from diagnosis.[1][3] This ensures that therapeutic drug levels are achieved quickly in severe infections. The dosing intervals and duration of therapy are crucial and should be adhered to based on the type of infection and patient response to treatment. Regular assessment for de-escalation based on clinical response and pathogen identification is also recommended to prevent overuse and resistance development.[1]

References

Reference 1

1.

Elsevier ClinicalKey Drug Monograph

Content last updated: May 6, 2024.

Indications And Dosage Intravenous dosage Adults: 4.5 g (4 g piperacillin and 0.5 g tazobactam) IV every 6 hours. Start within 1 hour for septic shock or within 3 hours for possible sepsis without shock. Duration of therapy is not well-defined and dependent on patient- and infection-specific factors. Assess patient daily for deescalation of antimicrobial therapy based on pathogen identification and/or adequate clinical response. Infants, Children, and Adolescents: 80 mg/kg/dose piperacillin component (90 mg/kg/dose zosyn powder) IV every 6 hours (Max: 4 g/dose piperacillin [4.5 g/dose zosyn powder]). Start within 1 hour for septic shock or within 3 hours for sepsis-associated organ dysfunction without shock. Duration of therapy is not well-defined and dependent on patient- and infection-specific factors. Assess patient daily for deescalation of antimicrobial therapy based on pathogen identification and/or adequate clinical response. Neonates older than 30 weeks postmenstrual age: 80 mg/kg/dose piperacillin component (90 mg/kg/dose zosyn powder) IV every 6 hours. Start within 1 hour for septic shock or within 3 hours for sepsis-associated organ dysfunction without shock. Duration of therapy is not well-defined and dependent on patient- and infection-specific factors. Assess patient daily for deescalation of antimicrobial therapy based on pathogen identification and/or adequate clinical response. Neonates younger than 37 weeks gestational age were excluded from guideline scope. Neonates 30 weeks postmenstrual age and younger: 100 mg/kg/dose piperacillin component (112.5 mg/kg/dose zosyn powder) IV every 8 hours.

Indications And Dosage Intravenous dosage Adults: 3.375 g (3 g piperacillin and 0.375 g tazobactam) IV every 6 to 8 hours for 14 to 21 days plus vancomycin in patients with underlying conditions. Infants † (off-label indication), Children† (off-label indication), and Adolescents† (off-label indication): 240 to 300 mg/kg/day piperacillin component (270 to 337.5 mg/kg/day zosyn powder) (Max: 3 g/dose piperacillin [3.375 g/dose zosyn powder]) IV divided every 6 to 8 hours for 14 to 21 days plus vancomycin in patients with underlying conditions. Neonates older than 30 weeks postmenstrual age † (off-label indication): 80 mg/kg/dose piperacillin component (90 mg/kg/dose zosyn powder) IV every 6 hours for 14 to 21 days plus vancomycin in patients with underlying conditions. Neonates 30 weeks postmenstrual age and younger † (off-label indication): 100 mg/kg/dose piperacillin component (112.5 mg/kg/dose zosyn powder) IV every 8 hours for 14 to 21 days plus vancomycin in patients with underlying conditions.

Indications And Dosage Intravenous dosage Adults: 4.5 g (4 g piperacillin and 0.5 g tazobactam) IV every 6 hours for at least 6 weeks as part of combination therapy. Infants, Children, and Adolescents: 80 mg/kg/dose piperacillin component (90 mg/kg/dose zosyn powder) (Max: 4 g/dose piperacillin [4.5 g/dose zosyn powder]) IV every 8 hours for at least 6 weeks as part of combination therapy. Neonates older than 30 weeks postmenstrual age: 80 mg/kg/dose piperacillin component (90 mg/kg/dose zosyn powder) IV every 6 hours for at least 6 weeks as part of combination therapy. Neonates 30 weeks postmenstrual age and younger: 100 mg/kg/dose piperacillin component (112.5 mg/kg/dose zosyn powder) IV every 8 hours for at least 6 weeks as part of combination therapy.

Indications And Dosage Intravenous dosage Adults: 3.375 g (3 g piperacillin and 0.375 g tazobactam) IV every 6 to 8 hours for 5 to 10 days plus incision and drainage. Infants † (off-label indication), Children† (off-label indication), and Adolescents† (off-label indication): 240 to 300 mg/kg/day piperacillin component (270 to 337.5 mg/kg/day zosyn powder) (Max: 3 g/dose piperacillin [3.375 g/dose zosyn powder]) IV divided every 6 to 8 hours for 5 to 10 days plus incision and drainage. Neonates older than 30 weeks postmenstrual age † (off-label indication): 80 mg/kg/dose piperacillin component (90 mg/kg/dose zosyn powder) IV every 6 hours for 5 to 10 days plus incision and drainage. Neonates 30 weeks postmenstrual age and younger † (off-label indication): 100 mg/kg/dose piperacillin component (112.5 mg/kg/dose zosyn powder) IV every 8 hours for 5 to 10 days plus incision and drainage.

Indications And Dosage Infants younger than 2 months † (off-label indication): 200 to 300 mg/kg/day piperacillin component (225 to 337.5 mg/kg/day zosyn powder) IV divided every 6 to 8 hours. Antibiotics should be discontinued within 24 hours. Uncomplicated infections include acute appendicitis without perforation, abscess, or local peritonitis; traumatic bowel perforations repaired within 12 hours; acute cholecystitis without perforation; and ischemic, non-perforated bowel.

Indications And Dosage Intravenous dosage Adults: 3.375 g (3 g piperacillin and 0.375 g tazobactam) IV every 6 to 8 hours for 5 to 14 days. Infants † (off-label indication), Children† (off-label indication), and Adolescents† (off-label indication): 240 to 300 mg/kg/day piperacillin component (270 to 337.5 mg/kg/day zosyn powder) (Max: 3 g/dose piperacillin [3.375 g/dose zosyn powder]) IV divided every 6 to 8 hours for 5 to 14 days. Neonates older than 30 weeks postmenstrual age † (off-label indication): 80 mg/kg/dose piperacillin component (90 mg/kg/dose zosyn powder) IV every 6 hours for 5 to 14 days. Neonates 30 weeks postmenstrual age and younger † (off-label indication): 100 mg/kg/dose piperacillin component (112.5 mg/kg/dose zosyn powder) IV every 8 hours for 5 to 14 days.

Reference 2

2.

Food and Drug Administration (DailyMed).

Publish date: March 3, 2023.

Dosage And Administration 2 DOSAGE AND ADMINISTRATION • If a dose of ZOSYN is required that does not equal 2.25 g, 3.375 g, or 4.5 g, ZOSYN injection in GALAXY Containers is not recommended for use and an alternative formulation of ZOSYN should be considered. ( 2.1 ) • Adult Patients With Indications Other Than Nosocomial Pneumonia; The usual daily dosage of ZOSYN for adults is 3.375 g every six hours totaling 13.5 g (12.0 g piperacillin and 1.5 g tazobactam). ( 2.2 ) • Adult Patients with Nosocomial Pneumonia: Initial presumptive treatment of patients with nosocomial pneumonia should start with ZOSYN at a dosage of 4.5 g every six hours plus an aminoglycoside, totaling 18.0 g (16.0 g piperacillin and 2.0 g tazobactam). ( 2.3 ) • Adult Patients with Renal Impairment : Dosage in patients with renal impairment (creatinine clearance ≤40 mL/min) and dialysis patients should be reduced, based on the degree of renal impairment.

Dosage And Administration Table 1: Recommended Dosage of ZOSYN in Patients with Normal Renal Function and Renal Impairment (As total grams piperacillin and tazobactam) Administer ZOSYN by intravenous infusion over 30 minutes. Creatinine clearance, mL/min All Indications (except nosocomial pneumonia) Nosocomial Pneumonia Greater than 40 mL/min 3.375 every 6 hours 4.5 every 6 hours 20 to 40 mL/min Creatinine clearance for patients not receiving hemodialysis 2.25 every 6 hours 3.375 every 6 hours Less than 20 mL/min 2.25 every 8 hours 2.25 every 6 hours Hemodialysis 0.75 g (0.67 g piperacillin and 0.08 g tazobactam) should be administered following each hemodialysis session on hemodialysis days 2.25 every 12 hours 2.25 every 8 hours CAPD 2.25 every 12 hours 2.25 every 8 hours For patients on hemodialysis, the maximum dose is 2.25 g every twelve hours for all indications other than nosocomial pneumonia and 2.25 g every eight hours for nosocomial pneumonia. Since hemodialysis removes 30% to 40% of the administered dose, an additional dose of 0.75 g ZOSYN (0.67 g piperacillin and 0.08 g tazobactam) should be administered following each dialysis period on hemodialysis days. No additional dosage of ZOSYN is necessary for CAPD patients. 2.5 Dosage in Pediatric Patients With Appendicitis/Peritonitis or Nosocomial Pneumonia The recommended dosage for pediatric patients with appendicitis and/or peritonitis or nosocomial pneumonia aged 2 months of age and older, weighing up to 40 kg, and with normal renal function, is described in Table 2 [see Use in Specific Populations (8.4) and Clinical Pharmacology (12.3) ].

Reference 3

3.

Food and Drug Administration (DailyMed).

Publish date: May 3, 2024.

Dosage And Administration ( 2.7 ) • See the full prescribing information for the preparation and administration instructions for Zosyn (piperacillin sodium and tazobactam sodium) Injection in GALAXY Containers. 2.1 Important Administration Instructions If a dose of Zosyn (piperacillin sodium and tazobactam sodium) is required that does not equal 2.25 g, 3.375 g, or 4.5 g, Zosyn (piperacillin sodium and tazobactam sodium) injection in GALAXY Containers is not recommended for use and an alternative formulation of Zosyn (piperacillin sodium and tazobactam sodium) should be considered. 2.2 Dosage in Adult Patients With Indications Other Than Nosocomial Pneumonia The usual total daily dosage of Zosyn (piperacillin sodium and tazobactam sodium) for adult patients with indications other than nosocomial pneumonia is 3.375 g every six hours [totaling 13.5 g (12.0 g piperacillin and 1.5 g tazobactam)], to be administered by intravenous infusion over 30 minutes. The usual duration of Zosyn (piperacillin sodium and tazobactam sodium) treatment is from 7 to 10 days. 2.3 Dosage in Adult Patients With Nosocomial Pneumonia Initial presumptive treatment of adult patients with nosocomial pneumonia should start with Zosyn (piperacillin sodium and tazobactam sodium) at a dosage of 4.5 g every six hours plus an aminoglycoside, [totaling 18.0 g (16.0 g piperacillin and 2.0 g tazobactam)], administered by intravenous infusion over 30 minutes. The recommended duration of Zosyn (piperacillin sodium and tazobactam sodium) treatment for nosocomial pneumonia is 7 to 14 days. Treatment with the aminoglycoside should be continued in patients from whom P. aeruginosa is isolated.

Follow up questions